Profile search results

You searched for profiles matching the following:

  • Department: Medical Genetics

The search produced 9 results.

Search again

  • Kate Baker Dr Kate Baker
    Genomic technology is now enabling the identification of many novel causes of neurodevelopmental disorder. This provides a new starting point for understanding the relationships between specific genetic mutation, neuronal function, brain developm...
  • Dr Maria Angeles Fernandez
    My main interest is the study of signalling pathways and molecular mechanisms involved in neurodegenerative diseases like Alzheimer's and Huntington's disease, and its use as a target for the possible therapy of these diseases. Actually, my rese...
  • Dr Maria Jimenez-Sanchez
    I am interested in the study of neurodegenerative diseases such as Huntington´s disease that are associated with the formation of intracellular protein aggregates. My research focuses on exploring the molecular mechanisms that cells employ to pr...
  • Mr Daniel Rainbow
    I study the genetics of autoimmune diseases.
  • Lucy Raymond Dr Lucy Raymond
    The group aims to understand the molecular mechanisms underlying intellectual disability in humans. Our main focus is on families with X linked disease. In collaboration with The Wellcome Trust Sanger Institute, we are using a new approach to dise...
  • Evan Reid Dr Evan Reid
    My group's research is focussed on the hereditary spastic paraplegias, genetic conditions where the corticospinal tract axons degenerate. HSPs selectively involve axons while sparing the neuronal cell bodies, so we study them to understand molecul...
  • Dr Tim Rooney
    I am a research associate at the Alzheimer's Research UK Drug Discovery Institute where I work as a medicinal chemist on a variety of projects related to neurodegeneration. With expertise in drug discovery, organic chemistry and chemical biology, ...
  • David  Rubinsztein Professor David Rubinsztein
    The pathogenesis of diseases caused by codon reiteration mutations (like Huntington’s disease and oculopharangeal muscular dystrophy). Description of research: We are studying the pathogenesis of diseases caused by codon reiteration mutations, l...
  • John Skidmore Dr John Skidmore
    I am a medicinal chemist and drug discovery leader interested in working collaboratively with academics and industry in order to translate basic neurodegeneration research into potential new treatments. The Alzheimer’s Research UK Cambridge Drug ...

Search again